Author

Feilong Chen

Chongqing UniversityORCID 0000-0002-3253-8097Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Jing FengiD· 1 shared Keli LiuiD· 1 shared Meng WangiD· 1 shared Reziyamu WufueriD· 1 shared Shanshan LiniD· 1 shared Shaofan HuiD· 1 shared Yiguo ZhangiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Jing FengORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cell BiologyFree Radical Biology and MedicinePeer-reviewedJan 24, 2024

Distinct mechanisms by which antioxidant transcription factors Nrf1 and Nrf2 as drug targets contribute to the anticancer efficacy of Cisplatin on hepatoma cells

Reziyamu Wufuer, Keli Liu, Jing Feng…·Yiguo Zhang

This study investigates how antioxidant transcription factors Nrf1 and Nrf2 influence the anticancer effect of Cisplatin on hepatoma cells through distinct molecular mechanisms.

12 citations

humanbulk RNA-seq

𝕏 PostBluesky